Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11,637 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prioritization of Generic Drug Review-Reply.
Gupta R, Kesselheim AS, Ross JS. Gupta R, et al. JAMA Intern Med. 2017 Jan 1;177(1):141-142. doi: 10.1001/jamainternmed.2016.7817. JAMA Intern Med. 2017. PMID: 28030736 No abstract available.
Generic Drug Approvals Since the 1984 Hatch-Waxman Act.
Gupta R, Kesselheim AS, Downing N, Greene J, Ross JS. Gupta R, et al. JAMA Intern Med. 2016 Sep 1;176(9):1391-3. doi: 10.1001/jamainternmed.2016.3411. JAMA Intern Med. 2016. PMID: 27428055 No abstract available.
The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.
Gupta R, Dhruva SS, Fox ER, Ross JS. Gupta R, et al. J Manag Care Spec Pharm. 2017 Oct;23(10):1066-1076. doi: 10.18553/jmcp.2017.23.10.1066. J Manag Care Spec Pharm. 2017. PMID: 28944731 Clinical Trial.
Gupta and Ross were responsible for the conception and design of this work, drafted the manuscript, and conducted the statistical analysis. Gupta and Fox were responsible for acquisition of data. Ross provided supervision. All authors participated in the analysis an
Gupta and Ross were responsible for the conception and design of this work, drafted the manuscript, and conducted the statistical ana
High Costs of FDA Approval for Formerly Unapproved Marketed Drugs.
Hakim A, Gupta R, Ross JS. Hakim A, et al. JAMA. 2017 Dec 12;318(22):2181-2182. doi: 10.1001/jama.2017.16481. JAMA. 2017. PMID: 29131905 No abstract available.
The Impact of Off-Patent Drug Acquisitions on Prices.
Gupta R, Henkel A, Forman HP, Ross JS. Gupta R, et al. J Gen Intern Med. 2018 Jul;33(7):1007-1009. doi: 10.1007/s11606-018-4372-3. J Gen Intern Med. 2018. PMID: 29687433 Free PMC article. No abstract available.
Generic Drugs in the United States: Policies to Address Pricing and Competition.
Gupta R, Shah ND, Ross JS. Gupta R, et al. Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10. Clin Pharmacol Ther. 2019. PMID: 30471089 Free PMC article.
Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.
Vijay A, Gupta R, Liu P, Dhruva SS, Shah ND, Ross JS. Vijay A, et al. J Gen Intern Med. 2020 Jun;35(6):1928-1930. doi: 10.1007/s11606-019-05432-6. Epub 2019 Oct 17. J Gen Intern Med. 2020. PMID: 31625043 No abstract available.
Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration.
Jiao K, Gupta R, Fox E, Kesselheim A, Ross JS. Jiao K, et al. JAMA Netw Open. 2019 Oct 2;2(10):e1913029. doi: 10.1001/jamanetworkopen.2019.13029. JAMA Netw Open. 2019. PMID: 31603482 Free PMC article.
The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.
Gupta R, Shah ND, Ross JS. Gupta R, et al. N Engl J Med. 2016 Dec 8;375(23):2213-2215. doi: 10.1056/NEJMp1609578. N Engl J Med. 2016. PMID: 27959694 No abstract available.
11,637 results
Jump to page
Feedback